Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/22221751.2020.1741327

http://scihub22266oqcxt.onion/10.1080/22221751.2020.1741327
suck pdf from google scholar
32208840!7103696!32208840
unlimited free pdf from europmc32208840    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32208840 :   free
PDF vom PMID32208840 :   free

suck abstract from ncbi

pmid32208840
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Clinical observation and management of COVID-19 patients #MMPMID32208840
  • Li T; Lu H; Zhang W
  • Emerg Microbes Infect 2020[Dec]; 9 (1): 687-690 PMID32208840show ga
  • Three leading infectious disease experts in China were invited to share their bedside observations in the management of COVID-19 patients. Professor Taisheng Li was sent to Wuhan to provide frontline medical care. He depicts the clinical course of SARS-CoV-2 infection. Furthermore, he observes the significant abnormality of coagulation function and proposes that the early intravenous immunoglobulin and low molecular weight heparin anticoagulation therapy are very important. Professor Hongzhou Lu, a leader in China to try various anti-viral drugs, expresses concern on the quality of the ongoing clinical trials as most trials are small in scale and repetitive in nature, and emphasizes the importance of the quick publication of clinical trial results. Regarding the traditional Chinese medicine, Professor Lu suggests to develop a creative evaluation system because of the complicated chemical compositions. Professor Wenhong Zhang is responsible for Shanghai's overall clinical management of the COVID-19 cases. He introduces the team approach to manage COVID-19 patients. For severe or critically ill patients, in addition to the respiratory supportive treatment, timely multiorgan evaluation and treatment is very crucial. The medical decisions and interventions are carefully tailored to the unique characteristics of each patient.
  • |*Betacoronavirus[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |China[MESH]
  • |Clinical Trials as Topic[MESH]
  • |Coronavirus Infections/drug therapy/mortality/*physiopathology/*therapy[MESH]
  • |Critical Illness[MESH]
  • |Disease Progression[MESH]
  • |Female[MESH]
  • |Glucocorticoids/therapeutic use[MESH]
  • |Humans[MESH]
  • |Male[MESH]
  • |Medicine, Chinese Traditional[MESH]
  • |Pandemics[MESH]
  • |Patient Care Management[MESH]
  • |Patient Care Team[MESH]
  • |Pneumonia, Viral/drug therapy/mortality/*physiopathology/*therapy[MESH]
  • |Thrombophilia/physiopathology/therapy[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    687 1.9 2020